Bradenton, FL — Blake Medical Center has been chosen as a one of only twenty hospitals nation-wide to participate in a global clinical trial for beating heart, mitral valve repair. The RECHORD trial is investigating a new device which allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating.
“In this trial, we can offer patients in our community that are suffering from degenerative mitral valve regurgitation, an opportunity to help us evaluate a new minimally invasive mitral valve repair technology on a beating heart that may change the way we treat patients in the near future,” said Dr. Alessandro Golino, MD, Cardiothoracic Surgeon.
During traditional mitral valve surgery, surgeons often have to go through the sternum and stop the heart to access the mitral valve. With the NeoChord procedure, surgeon investigators can use the device while the heart is beating and functioning to gain access to the heart and repair the mitral valve regurgitation while using echo guidance (echocardiogram).
“Blake is committed to providing exceptional and advanced heart care services to our community. We are pleased that we have been selected to participate in the RECHORD trial and with the opportunity to partner with leading cardiac centers around the world in this exciting investigation,” said Dan Friedrich, CEO of Blake Medical Center.
For more information or to schedule an interview, please contact Melissa Morgan at 941-798-6056 or Melissa.Morgan@HCAhealthcare.com